Verition Fund Management »

Supernus Pharmaceuticals shares owned by Verition Fund Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $392k 12k 34.11
2023-09-30 $270k 9.8k 27.57
2019-12-31 $1.5M 63k 23.70
2019-06-30 $1.2M 36k 33.09
2014-09-30 $116k 13k 8.71

More positions owned by Verition Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
salesforce Call Option (CRM)
Apple Call Option (AAPL)
Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Ishares Msci Brazil Etf Put Option (EWZ)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Goldman Sachs (GS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Sea Note 2.375%12/0 (Principal)

View all positions for Verition Fund Management

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Armistice Capital
Dimensional Fund Advisors
Stephens Investment Management Group
Loomis, Sayles and
Jennifer Ranahan
Geode Capital Management
Woodline Partners
Aristotle Capital Boston
Congress Asset Management
Pictet Asset Management Holding SA
Ashford Capital Management
Morgan Stanley
Victory Capital Management

View all funds holding Supernus Pharmaceuticals